These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37678260)

  • 1. A Paradigm Shift in Heart Preservation: Improved Post-transplant Outcomes in Recipients of Donor Hearts Preserved With the SherpaPak System.
    Shudo Y; Leacche M; Copeland H; Silvestry S; Pham SM; Molina E; Schroder JN; Sciortino CM; Jacobs JP; Kawabori M; Meyer DM; Zuckermann A; D'Alessandro DA
    ASAIO J; 2023 Nov; 69(11):993-1000. PubMed ID: 37678260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recipient Outcomes With Extended Criteria Donors Using Advanced Heart Preservation: An Analysis of the GUARDIAN-Heart Registry.
    Moayedifar R; Shudo Y; Kawabori M; Silvestry S; Schroder J; Meyer DM; Jacobs JP; D'Alessandro D; Zuckermann A
    J Heart Lung Transplant; 2024 Apr; 43(4):673-680. PubMed ID: 38163452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in Heart Transplant Recipients by Bridge to Transplant Strategy When Using the SherpaPak Cardiac Transport System.
    Silvestry S; Leacche M; Meyer DM; Shudo Y; Kawabori M; Mahesh B; Zuckermann A; D'Alessandro D; Schroder J
    ASAIO J; 2024 May; 70(5):388-395. PubMed ID: 38300893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of controlled hypothermic preservation on outcomes following heart transplantation.
    D'Alessandro D; Schroder J; Meyer DM; Vidic A; Shudo Y; Silvestry S; Leacche M; Sciortino CM; Rodrigo ME; Pham SM; Copeland H; Jacobs JP; Kawabori M; Takeda K; Zuckermann A
    J Heart Lung Transplant; 2024 Jul; 43(7):1153-1161. PubMed ID: 38503386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System.
    Lerman JB; Patel CB; Casalinova S; Nicoara A; Holley CL; Leacche M; Silvestry S; Zuckermann A; D'Alessandro DA; Milano CA; Schroder JN; DeVore AD
    Circ Heart Fail; 2024 May; 17(5):e010904. PubMed ID: 38602105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early elevated donor-derived cell-free DNA levels in heart transplant recipients following precision-controlled cardiac transport system or ice-cooled organ transport.
    Alam A; van Zyl JS; Afzal A; Felius J; Hall SA; Meyer DM; Carey SA
    Clin Transplant; 2023 Dec; 37(12):e15151. PubMed ID: 37922318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Packing the donor heart: Is SherpaPak cold preservation technique safer compared to ice cold storage.
    Bitargil M; Haddad O; Pham SM; Garg N; Jacob S; El-Sayed Ahmed MM; Landolfo K; Patel PC; Goswami RM; Leoni Moreno JC; Yip DS; Sareyyupoglu B
    Clin Transplant; 2022 Aug; 36(8):e14707. PubMed ID: 35543679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of Paragonix Sherpapak Cardiac Transport System for the Preservation of Donor Hearts After Circulatory Death.
    Urban M; Castleberry AW; Siddique A; Lowes BD; Stoller DA; Lundgren SW; Um JY
    Transplant Proc; 2023 Nov; 55(9):1997-2002. PubMed ID: 37739830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Registry Using Propensity Score Analysis to Compare a Novel Transport/Preservation System to Traditional Means on Postoperative Hospital Outcomes and Costs for Heart Transplant Patients.
    Voigt JD; Leacche M; Copeland H; Wolfe SB; Pham SM; Shudo Y; Molina E; Jacobs JP; Stukov Y; Meyer D; Philpott J; Kawabori M; Schroder J; Silvestry S; D'Alessandro D
    ASAIO J; 2023 Apr; 69(4):345-349. PubMed ID: 36399786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of Ischemia-Reperfusion Injury in Heart Transplantation: A Single-Center Study Evaluating Conventional Ice-Cold Storage versus the Paragonix SherpaPak Cardiac Transport System.
    Lotan D; Moeller CM; Rahman A; Rubinstein G; Oren D; Mehlman Y; Valledor AF; DeFilippis EM; Raikhelkar J; Clerkin K; Fried J; Majure D; Naka Y; Kaku Y; Takeda K; Oh KT; Yunis A; Colombo PC; Yuzefpolskaya M; Latif F; Sayer G; Uriel N; Sekulic M
    Clin Transplant; 2024 Jul; 38(7):e15397. PubMed ID: 39007406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial.
    Schroder JN; Patel CB; DeVore AD; Casalinova S; Koomalsingh KJ; Shah AS; Anyanwu AC; D'Alessandro DA; Mudy K; Sun B; Strueber M; Khaghani A; Shudo Y; Esmailian F; Liao K; Pagani FD; Silvestry S; Wang IW; Salerno CT; Absi TS; Madsen JC; Mancini D; Fiedler AG; Milano CA; Smith JW
    JACC Heart Fail; 2024 Mar; 12(3):438-447. PubMed ID: 38276933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep.
    See Hoe LE; Li Bassi G; Wildi K; Passmore MR; Bouquet M; Sato K; Heinsar S; Ainola C; Bartnikowski N; Wilson ES; Hyslop K; Skeggs K; Obonyo NG; Shuker T; Bradbury L; Palmieri C; Engkilde-Pedersen S; McDonald C; Colombo SM; Wells MA; Reid JD; O'Neill H; Livingstone S; Abbate G; Haymet A; Jung JS; Sato N; James L; He T; White N; Redd MA; Millar JE; Malfertheiner MV; Molenaar P; Platts D; Chan J; Suen JY; McGiffin DC; Fraser JF
    J Heart Lung Transplant; 2023 Aug; 42(8):1015-1029. PubMed ID: 37031869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-Hour Hypothermic Machine Perfusion for Donor Heart Preservation Leads to Improved Ultrastructural Characteristics Compared to Conventional Cold Storage.
    Michel SG; La Muraglia GM; Madariaga ML; Titus JS; Selig MK; Farkash EA; Allan JS; Anderson LM; Madsen JC
    Ann Transplant; 2015 Aug; 20():461-8. PubMed ID: 26259549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled temperatures in cold preservation provides safe heart transplantation results.
    Bitargil M; Haddad O; Pham SM; Goswami RM; Patel PC; Jacob S; El-Sayed Ahmed MM; Leoni Moreno JC; Yip DS; Landolfo K; Sareyyupoglu B
    J Card Surg; 2022 Apr; 37(4):732-738. PubMed ID: 35060167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death.
    Ayer A; Truby LK; Schroder JN; Casalinova S; Green CL; Bishawi MA; Bryner BS; Milano CA; Patel CB; Devore AD
    J Card Fail; 2023 Jan; 29(1):67-75. PubMed ID: 36351494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Paragonix SherpaPak for human donor heart preservation.
    Mohite PN; Sef D; Umakumar K; Maunz O; Smail H; Stock U
    Multimed Man Cardiothorac Surg; 2021 Jun; 2021():. PubMed ID: 34143579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(3):1-90. PubMed ID: 32190164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor predicted heart mass as predictor of primary graft dysfunction.
    Gong TA; Joseph SM; Lima B; Gonzalez-Stawinski GV; Jamil AK; Felius J; Qin H; Saracino G; Rafael AE; Kale P; Hall SA
    J Heart Lung Transplant; 2018 Jul; 37(7):826-835. PubMed ID: 29699850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.